Ahad, Marvad
Wallace, Jack
Xiao, Yinzong
van Gemert, Caroline
Bennett, Gabrielle
Darby, Jonathan
Desmond, Paul
Hall, Samuel
Holmes, Jacinta
Papaluca, Tim
Glasgow, Susanne
Thompson, Alexander
Hellard, Margaret
Doyle, Joseph
Howell, Jessica
Article History
Received: 12 August 2021
Accepted: 15 March 2022
First Online: 23 April 2022
Declarations
:
: Ethics approval for all experimental protocols was obtained from the Alfred Hospital Human Research Ethics Committee (HREC 149/19).Informed consent was obtained from all participants.All methods were carried out in accordance with relevant guidelines and regulations.
: Consent for publication was obtained from all study participants.
: JH has received speaker fees and investigator-initiated grants from Gilead Sciences. JD reports funding to his institution for investigator-initiated research from Gilead Sciences and Abbvie; and consultancies from Gilead Sciences and Abbvie. MH receives funding from Gilead Sciences and Abbvie for investigator-initiated research. AT has received consulting fees from Gilead, Abbvie, Roche, BMS, Merck, Immunocore, Janssen, Assembly Biosciences, Arbutus, Eisai, Ipsen and Bayer, speaker fees from Gilead Sciences, and investigator-initiated grants from Gilead Sciences. Burnet Institute acknowledges support from the Victorian Government Operational Infrastructure Fund.